As a leading provider of services to Covered Entities participating in the 340B Drug Pricing Program, Wellpartner is committed to identifying and analyzing all of the key issues affecting the Program, and sharing our point of view with you. Being at the forefront of change positions Wellpartner and our clients to positively influence the future, as well as prepare for it.